Results 51 to 60 of about 2,891 (200)

International review of blood donation screening for anti‐HBc and occult hepatitis B virus infection

Transfusion, Volume 64, Issue 11, Page 2144-2156, November 2024.
Abstract Background Hepatitis B core antibody (anti‐HBc) screening has been implemented in many blood establishments to help prevent transmission of hepatitis B virus (HBV), including from donors with occult HBV infection (OBI). We review HBV screening algorithms across blood establishments globally and their potential effectiveness in reducing ...
Michael X. Fu, Helen M. Faddy, Daniel Candotti, Jamel Groves, Paula Saa, Claire Styles, Opeyemi Adesina, Jose Perez Carrillo, Axel Seltsam, Marijke Weber‐Schehl, Sheila F. O'Brien, Steven J. Drews, Nana Benyin Aidoo, Ángel Luis Pajares, Laura Navarro Perez, Xuelian Deng, Thijs van de Laar, Syria Laperche, Riikka Lehtisalo, Soner Yilmaz, Wai‐Chiu Tsoi, David Juhl, Christoph Niederhauser, Nahid Chenarsabz, Niamh O'Flaherty, Naoko Goto, Masahiro Satake, Christian Renaud, Antoine Lewin, Marc Cloutier, Salam Sawadogo, Claire Reynolds, Eugene Zhiburt, An Muylaert, Véronique Van Gaever, Michel‐Andres Garcia‐Otalora, Lisa Jarvis, Marion Vermeulen, Michael Busch, Stuart Blackmore, Ann Jones, Su Brailsford, William L. Irving, Monique Andersson, Peter Simmonds, Heli Harvala, on behalf of the Virology subgroup of the ISBT WP‐TTID   +46 more
wiley   +1 more source

An international review of the characteristics of viral nucleic acid‐amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT

Vox Sanguinis, Volume 119, Issue 7, Page 745-751, July 2024.
Abstract Background and Objectives Nucleic acid‐amplification testing (NAT) is used for screening blood donations/donors for blood‐borne viruses. We reviewed global viral NAT characteristics and NAT‐yield confirmatory testing used by blood operators.
Helen M. Faddy, Carla Osiowy, Brian Custer, Michael Busch, Susan L. Stramer, Melinda M. Dean, Jessika Acutt, Elvina Viennet, Thijs van de Laar, Wai‐Chiu Tsoi, Claire Styles, Phil Kiely, Angelo Margaritis, So‐Yong Kwon, Yan Qiu, Xuelian Deng, Antoine Lewin, Signe Winther Jørgensen, Christian Erikstrup, David Juhl, Silvia Sauleda, Bernardo Armando Camacho Rodriguez, Lisbeth Jennifer Catherine Soto Coral, Paula Andrea Gaviria García, Sineenart Oota, Sheila F. O'Brien, Silvano Wendel, Emma Castro, Laura Navarro Pérez, Heli Harvala, Katy Davison, Claire Reynolds, Lisa Jarvis, Piotr Grabarczyk, Aneta Kopacz, Magdalena Łętowska, Niamh O'Flaherty, Fiona Young, Padraig Williams, Lisa Burke, Sze Sze Chua, An Muylaert, Isabel Page, Ann Jones, Christoph Niederhauser, Marion Vermeulen, Syria Laperche, Pierre Gallian, Masahiro Satake, Marcelo Addas‐Carvalho, Sebastián Blanco, Sandra V. Gallego, Axel Seltsam, Marijke Weber‐Schehl, Arwa Z. Al‐Riyami, Khuloud Al Maamari, Fatma Ba Alawi, Hem Chandra Pandey, Rochele Azevedo França, Richard Charlewood, on behalf of the Virology and Surveillance, Risk Assessment and Policy subgroups of the ISBT WP‐TTID   +61 more
wiley   +1 more source

International review of blood donation nucleic acid amplification testing

Vox Sanguinis, Volume 119, Issue 4, Page 315-325, April 2024.
Abstract Background and Objectives Nucleic acid amplification testing (NAT), in blood services context, is used for the detection of viral and parasite nucleic acids to reduce transfusion‐transmitted infections. This project reviewed NAT for screening blood donations globally.
Helen M. Faddy, Carla Osiowy, Brian Custer, Michael Busch, Susan L. Stramer, Opeyemi Adesina, Thijs van de Laar, Wai‐Chiu Tsoi, Claire Styles, Phil Kiely, Angelo Margaritis, So‐Yong Kwon, Yan Qiu, Xuelian Deng, Antoine Lewin, Signe Winther Jørgensen, Christian Erikstrup, David Juhl, Silvia Sauleda, Bernardo Armando Camacho Rodriguez, Lisbeth Jennifer Catherine Soto Coral, Paula Andrea Gaviria García, Sineenart Oota, Sheila F. O'Brien, Silvano Wendel, Emma Castro, Laura Navarro Pérez, Heli Harvala, Katy Davison, Claire Reynolds, Lisa Jarvis, Piotr Grabarczyk, Aneta Kopacz, Magdalena Łętowska, Niamh O'Flaherty, Fiona Young, Padraig Williams, Lisa Burke, Sze Sze Chua, An Muylaert, Isabel Page, Ann Jones, Christoph Niederhauser, Marion Vermeulen, Syria Laperche, Pierre Gallian, Salam Sawadogo, Masahiro Satake, Ahmad Gharehbaghian, Marcelo Addas‐Carvalho, Sebastián Blanco, Sandra V. Gallego, Axel Seltsam, Marijke Weber‐Schehl, Arwa Z. Al‐Riyami, Khuloud Al Maamari, Fatma Ba Alawi, Hem Chandra Pandey, Dora Mbanya, Rochele Azevedo França, Richard Charlewood, on behalf of the Virology and Surveillance; Risk Assessment and Policy subgroups of the ISBT Working Party on Transfusion‐transmitted Infectious Diseases   +61 more
wiley   +1 more source

Reacción transfusional hemolítica retardada por aloanticuerpo anti-E

Revista Información Científica, 2019
Se presentó el caso de una señora de 47 años, grupo sanguíneo O Rh D positivo, G4P2A2, sin antecedente transfusional, que requería intervención quirúrgica por fibroma uterino sangrante.
Niurka Aurora Ali Pérez, Ariel Arturo Matos Bayeau, Marlene Rodríguez Ruiz   +2 more
doaj  

Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico

Viruses
Booster doses of the SARS-CoV-2 vaccine have been recommended to improve and prolong immunity, address waning immunity over time, and contribute to the control of the COVID-19 pandemic.
Yanet Ventura-Enríquez, Evelyn Cortina-De la Rosa, Elizabeth Díaz-Padilla, Sandra Murrieta, Silvia Segundo-Martínez, Verónica Fernández-Sánchez, Cruz Vargas-De-León   +6 more
doaj   +1 more source

Factors related to the development of high antibody titres against SARS‐CoV‐2 in convalescent plasma donors from the ConPlas‐19 trial

Vox Sanguinis, Volume 119, Issue 1, Page 27-33, January 2024.
Abstract Background and Objectives The efficacy of COVID‐19 convalescent plasma (CP) associates with high titres of antibodies. ConPlas‐19 clinical trial showed that CP reduces the risk of progression to severe COVID‐19 at 28 days. Here, we aim to study ConPlas‐19 donors and characteristics that associate with high anti‐SARS‐CoV‐2 antibody levels ...
Irene Romera Martínez, Cristina Avendaño‐Solá, Carolina Villegas Da Ros, Alba Bosch Llobet, José Antonio García Erce, María Isabel González Fraile, Luisa Guerra Domínguez, Isabel Vicuña Andrés, Javier Anguita Velasco, Victoria Paz González Rodríguez, Enric Contreras, Sabin Urcelay Uranga, Ángel Luis Pajares Herraiz, Teresa Jimenez‐Marco, Ana María Ojea Pérez, José Luis Arroyo Rodríguez, Mayte Pérez‐Olmeda, Antonio Ramos‐Martínez, Ana Velasco‐Iglesias, José Luis Bueno Cabrera, Rafael F. Duarte   +20 more
wiley   +1 more source

Aplicaci?n buscadora de bancos de sangre y donaci?n de sangre.

, 2022
Trabajo de Fin de Grado. Grado en Ingenier?a Inform?tica. Curso acad?mico 2021-2022.
openaire   +1 more source

Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS‐DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor

International Journal of Inflammation, Volume 2024, Issue 1, 2024.
Inflammatory and antimicrobial diseases constitute a major burden for society, and fighting them is a WHO strategic priority. Most of the treatments available to fight inflammatory diseases are anti‐inflammatory drugs, such as corticosteroids or immunomodulators that lack cellular specificity and lead to numerous side effects.
Claire Lacombe, Estefania Aleman-Navaro, Thierry Drujon, Veronica Martinez-Osorio, Emmanuelle Sachon, Erika Melchy-Pérez, Ludovic Carlier, Lorena Elizabeth Fajardo Brigido, Yannick Fleury, Christophe Piesse, Guadalupe Gutiérrez-Escobedo, Alejandro De las Peñas, Irene Castaño, Florie Desriac, Jose Luis Beristain-Hernandez, Christophe Combadiere, Yvonne Rosenstein, Constance Auvynet, Andrew Day   +18 more
wiley   +1 more source

Blood Donation and Citizenship Education. An approach from service learning and the Theory of Don

Teoría de la Educación: Revista Interuniversitaria, 2014
The altruistic donation of blood recommended by the World Health Organisation and carried out through blood banks not only contributes to providing the health system with an indispensable therapeutic element, it is also a means of fostering social ...
Josep M. PUIG ROVIRA, Mariona GRAELL MARTÍN, Gal·la CORTEL MAÑÉ   +2 more
doaj   +1 more source

Prevalencia De Anticuerpos Irregulares En Donantes Del Banco De Sangre De Córdoba, Montería 2012-2015 [PDF]

, 2018
Objetivo: determinar la prevalencia de anticuerpos irregulares en donantes del Banco de sangre de Córdoba en Montería durante el periodo de 2012 a 2015.
Hoyos González, Kenia María, Correa Ortega, Andrea   +1 more
core